Page last updated: 2024-10-25

cycloleucine and Nervous System Disorders

cycloleucine has been researched along with Nervous System Disorders in 1 studies

Cycloleucine: An amino acid formed by cyclization of leucine. It has cytostatic, immunosuppressive and antineoplastic activities.
1-aminocyclopentanecarboxylic acid : A non-proteinogenic alpha-amino acid that is cyclopentane substituted at position 1 by amino and carboxy groups.

Research Excerpts

ExcerptRelevanceReference
"Cycloleucine was administered as a single dose intraperitoneally (2 mg/g body weight) to young mice aged 21 d and adults aged 6 or 10 wks."1.28Distal motor axonopathy and central nervous system myelin vacuolation caused by cycloleucine, an inhibitor of methionine adenosyltransferase. ( Duchen, LW; Lee, CC; Surtees, R, 1992)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lee, CC1
Surtees, R1
Duchen, LW1

Other Studies

1 other study available for cycloleucine and Nervous System Disorders

ArticleYear
Distal motor axonopathy and central nervous system myelin vacuolation caused by cycloleucine, an inhibitor of methionine adenosyltransferase.
    Brain : a journal of neurology, 1992, Volume: 115 ( Pt 3)

    Topics: Animals; Axons; Cycloleucine; Female; Male; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB

1992